Head-to-head · WeighScore
Effecty vs Push Health
By GLP-1 ScorecardUpdated
Score comparison
Effecty has the higher recorded score — 83.7/100 to 56.2/100.
Effecty grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Separate compounded/branded offers; confirm discounts, billing and exit terms.
Before you choose
Push Health does not publish a semaglutide price, so its Push Health review sets out what it does disclose, while the Effecty review explains the conditions attached to Effecty's figure. The semaglutide cost page compares published rates across the field. Ask Push Health for a written total before treating either one as the cheaper choice.
If neither one fits, Effecty vs Ravia Health and Gala Health vs Push Health compare each of them with another graded program, and the list of alternatives to Effecty ranks the programs closest to Effecty on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the Collective review covers one graded close to these two, at 71.6/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Effecty | Push Health |
|---|---|---|
| WeighScore | 83.7/100 | 56.2/100 |
| Grade | B | C |
| Site position | #21 | #451 |
| Semaglutide | $170/month before code; advertised $95 first month. Supply unconfirmed. | Not disclosed (site cites outside retail prices, not its own charge) |
| Tirzepatide | $235/month before code; advertised $160 first month. Supply unconfirmed. | Not disclosed |
| Coverage | Nationwide shipping claimed; confirm treatment-specific eligibility. | Coverage not published |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Not confirmed | Not confirmed |
Strengths
- Medication-specific billing terms
- Dose-independent pricing advertised
- Separate Wegovy offer published
What to consider
- Selected total/supply unconfirmed
- Prescription sales described as final
- Assigned pharmacy and individual credentials unverified
Strengths
- Brand-name-only GLP-1 distribution (Ozempic, Zepbound, Mounjaro)
- 55,000+ pharmacy network per competitor sources
- LegitScript certified per competitor sources
- Listed in both competitor directories
What to consider
- Brand-name-only — no compounded option
- We have not yet verified its pricing, insurance coordination or clinician workflow
- Unverified, so treat this listing as provisional
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.